BioTechX Day 2 update

Today at our booth

The second day of BioTechX has been filled with a wealth of exciting research. Take a look at some of our highlights below and make sure to let us know your thoughts in the comments below or on social media.

Remember you can find us at booth #804, or follow our Twitter updates .@FutMedicineAI

Daily highlights

https://twitter.com/FutMedicineAI/status/1709957003794071883

Must see talks

How patient based multi-omic data can better define and refine therapeutic target selection In this talk, Silvia von der Heyde (Indivumed GmbH; Hamburg, Germany) explains how comprehensive analysis of patient multi-omics data offers a more holistic view of molecular changes, providing a greater understanding of causal relationships across numerous levels of cellular organization, through integrating data from transcriptomics, epigenomics, metabolomics and proteomics platforms. Find out moreThe economic impact of AI in healthcare AI has the potential to enhance productivity through minimising repetitive laborious tasks, however, several hurdles need to be overcome to put these frameworks in place. In this talk Justus Wolff from the Technical University Munich (Germany) provides his thoughts on the key factors involved. Browse more fascinating talksHow to increase diversity in clinical trials using RWD There are many barriers to clinical trial diversity, including access, eligibility, social norms and attitudes, medical mistrust and enrolment practices. This talk discussed how lack of representation can be resolved using real-world data, which can reduce the risk of missing potential differences in drug side effect profiles, metabolism and trial results. Discover more

Best of social media #BioTechX

https://twitter.com/Prof_HN/status/1709934029817188412 https://twitter.com/FutMedicineAI/status/1709840849821982784 https://twitter.com/BioTechX_/status/1709936271005794441